> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Panel to Review Tuberculosis NDA
- URL: https://www.fdaweb.com/panel-to-review-tuberculosis-nda/
- Published: 2019-04-23T12:00:00.000Z
- Updated: 2026-09-15T01:21:53.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5143929

*Federal Register* notice: FDA has announced a 6/6 Antimicrobial Drugs Advisory Committee meeting to discuss a Global Alliance for TB Drug Development NDA for pretomanid tablets for oral administration. The submission seeks a proposed indication as part of a combination regimen with bedaquiline and linezolid in adults for treating pulmonary drug-resistant and treatment-intolerant or non-responsive multidrug-resistant tuberculosis. To view the notice, click [here](https://s3.amazonaws.com/public-inspection.federalregister.gov/2019-08175.pdf?ref=fdaweb.com).